Labcorp launches 3-part blood test for Alzheimer’s Therapeutics Although the profile is not precise enough to definitively diagnose Alzheimer’s, it offers a convenient way for doctors to determine which patients need advanced testing, according to the company. Read more October 11, 2023/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/07/Labcorp-logo.jpg 450 524 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2023-10-11 07:34:482023-10-11 09:14:06Labcorp launches 3-part blood test for Alzheimer's